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Abstract
Two meta-analysis of genome wide association studies identified two variants at adenylate
cyclase 5 (ADCY5) associated with type 2 diabetes mellitus, fasting and 2-hour glucose in
non-pregnant individuals of European descent. The objective of our study was to explore
the role of common variants in ADCY5 on gestational glycemic traits, including plasma glu-
cose, insulin values, β cell function and insulin resistance in the fasted state as well as
plasma glucose 1 hour after a 50-gram glucose challenge test among Chinese Han women.
Homoeostasis model assessment (HOMA) was used to quantify β cell function (HOMA1-β
and HOMA2-β) and insulin resistance (HOMA1-IR and HOMA2-IR). Thirty-five single nucle-
otide polymorphisms (SNPs) in ADCY5 were genotyped in 929 unrelated Chinese Han
women with singleton pregnancies. Three SNPs (rs6797915, rs9856662 and rs9875803)
displayed evidence for association with plasma glucose 1 hour after a 50-gram glucose chal-
lenge test (P = 0.042, 0.018 and 0.018, respectively), one (rs6777397) displayed evidence
for association with HOMA1-β (P = 0.014), and one (rs6762009) displayed evidence for
association with HOMA1-IR (P = 0.033). These results provide additional insight into the
effects of genetic variation within ADCY5 in glucose metabolism, especially during preg-
nancy and in non-European descent populations.
Introduction
Gestational glycemic traits and gestational diabetes mellitus (GDM) are usually the results of
the interplay between environmental and genetic factors [1, 2]. Published heritability estimates
for fasting plasma glucose (FPG) levels during pregnancy range between 30% and 71% [1].
Adverse pregnancy outcomes increase with increasing plasma glucose levels during pregnancy
[3]. These increases are continuous throughout the range of plasma glucose levels, even among
those levels under the cut-off points for the diagnosis of GDM. So it is difficult to ascertain a
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specific level at which elevated glucose levels become clinically significant. An international
consensus could not be reached on the optimal diagnostic cut-off points for GDM and thereby
diagnostic criteria for GDM used in studies are different [4]. Furthermore, the intermediate
phenotypes of GDM may provide more power to detect genetic variants compared with the
more distal clinical diagnosis. Therefore, in comparison with case-control studies of GDM,
description of the effects of genetic variants on gestational glycemic traits, such as FPG and
insulin sensitivity, may be better.
Adenylate cyclase 5 (ADCY5) is a member of the membrane-bound adenylate cyclase
(ADCY) family, which converts adenosine triphosphate (ATP) to the second messenger cyclic
adenosine monophosphate (cAMP) and pyrophosphate [5]. cAMP itself is a key regulator for
glucose and lipid metabolism [6, 7]. cAMP can regulate glucose-induced insulin secretion
through several possible mechanisms [7, 8]. ADCY5 may be the most abundant member of the
ADCY family in human islets [9, 10]. ADCY5 couples glucose to insulin secretion by convert-
ing glucose signals into cAMP production [11]. Genome wide association studies (GWASs)
have revealed variants at ADCY5 associated with type 2 diabetes mellitus (T2DM), fasting and
2-hour glucose [12, 13]. The genetic etiology of GDM has been documented to overlap that of
T2DM [2]. However, knowledge regarding the genetic risk variants in ADCY5 for GDM and
glycemic traits in pregnancy is limited, although two studies have found an association
between ADCY5 variant and GDM [14, 15]. It remains unclear whether ADCY5 variants are
associated with glycemic traits in pregnancy. We therefore tested the hypothesis.
In this study, we conducted a cross-sectional study to assess the influence of common vari-
ants in ADCY5 on gestational glycemic traits, including fasting plasma glucose and insulin, β
cell function, insulin resistance as well as plasma glucose 1 hour after a 50-gram glucose chal-
lenge test among pregnant women. Further, for better evaluation, 35 tagging single nucleotide
polymorphisms (SNPs) were selected to cover the known common variants of ADCY5.
Materials and methods
Study population
This study enrolled 929 unrelated Chinese Han women with singleton pregnancies from Tai-
zhou People’s Hospital between 2010–2013. The participants were aged between 19 and 42
(mean: 26.8±3.8) years. Most of the antenatal check-ups for all participants were performed in
Taizhou People’s Hospital. A screening test (50-gram 1-hour glucose challenge test) for GDM
after overnight fasting of 8 to14 hours was offered to all participants around 24–28 weeks’ ges-
tation. Fasting glucose and insulin levels were also measured at the same time. For those partic-
ipants whose FPG�5.6 mmol/l or plasma glucose 1 hour after a 50-gram glucose challenge
test�7.8 mmol/l, a diagnostic two-hour, 75-gram oral glucose tolerance test (OGTT) was con-
ducted within one week. Plasma glucose was detected using a hexokinase reaction on a Cobas
P800 analyzer (Roche Diagnostics GmbH, Mannheim, Germany). Plasma insulin was deter-
mined by an electrochemiluminescence assay on a Cobas e601 platform (Roche Diagnostics
GmbH, Mannheim, Germany). FPG levels of almost 94.4% of participants were lower than 5.6
mmol/l. Women who reportedly received treatment against diabetes before the screening test
were not included. To exclude the effects of assisted reproduction, this study only enrolled
women who naturally conceived. In order to avoid sampling errors, all eligible pregnant
women were invited, regardless of age and occupation. As long as they were willing to partici-
pate, they would be collected.
Homoeostasis model assessment (HOMA) was used to estimate basal β cell function and
insulin resistance. HOMA1 β cell function (HOMA1-β) index was defined as (20×fasting insu-
lin)/(fasting glucose-3.5). HOMA1 insulin resistance (HOMA1-IR) index was calculated as
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fasting insulin×fasting glucose/22.5. When FPG levels are�3.5 mmol/l, HOMA1-β can not be
estimated and thereby HOMA1-β values of 20 subjects were unavailable. HOMA2-β and
HOMA2-IR indices were estimated with the HOMA2 calculator version 2.2 released by the
Diabetes Trials Unit at the Oxford Centre for Diabetes, Endocrinology and Metabolism, Uni-
versity of Oxford (�if Glucose: 3.0 to 25.0 mmol/l and Insulin: 20 to 400 pmol/l) [16, 17].
HOMA2-β and HOMA2-IR indices of 844 participants were obtainable. According to Wallace
et al. [17], HOMA2 more accurately indicates the metabolic process because it models the
feedback relation between insulin and glucose in various organs of the human body.
HOMA1-IR primarily manifests hepatic insulin resistance, and HOMA2-IR manifests hepatic
and peripheral insulin resistance [17–19].
Genomic DNA was isolated from venous blood samples which were drawn from the partic-
ipants in the days surrounding the delivery. Ethical approval was provided by the Ethics Com-
mittee of Hainan Medical University and Fudan University Taizhou Institute of Health
Sciences. All participants gave written, informed consent. Basic characteristics of all partici-
pants are shown in Table 1. Fifty-one participants had missing fasting insulin data and forty-
eight had missing 50-g 1-h glucose data.
SNP genotyping
Thirty-five tag SNPs across the ADCY5 gene (chromosome 3: 123,282,296..123,459,758 177.46
kbp, human genome reference assembly GRCh38/hg38), including rs6801826, rs6777397,
rs10049128, rs9857526, rs10934643, rs4678005, rs12633873, rs6770805, rs9870651, rs4234214,
rs13058985, rs6806851, rs4678008, rs4678010, rs4677884, rs4450740, rs4596093, rs6795648,
rs2332510, rs11923120, rs6797915, rs12496583, rs6794936, rs9856662, rs12486065, rs7616545,
rs7641344, rs9875803, rs6774571, rs6762009, rs4677889, rs9841477, rs4678030, rs13072153
and rs2046487, were identified according to linkage disequilibrium (LD) patterns in the phase
III Han Chinese in Beijing (CHB) and Southern Han Chinese (CHS) populations with r2
thresholds of 0.90 and minor allele frequency (MAF) thresholds of 0.05 (data derived from
the 1000 Genomes Project, based on GRCh38). A list of the included SNPs is provided in
S1 Table.
Table 1. Basic characteristics of study participants.
Characteristics N
Age at childbirth, years 926 26.8±3.8
Spouse’s age at childbirth, years 923 28.2±4.4
Neonatal sex, % male 927 52.90%
Prepregnancy gravidity 927 0.7±1.0
Prepregnancy parity 927 0.2±0.4
Prepregnancy BMI, kg/m2 915 20.6±2.6
24-28-week fasting plasma glucose, mmol/l 929 4.54±0.62
24-28-week fasting plasma insulin, pmol/l 878 63.52±73.30
24-28-week 1-hour plasma glucose after a 50-gram glucose challenge test, mmol/l 881 7.13±1.45
HOMA1-β 858 226.54±253.05
HOMA1-IR 858 1.90±2.58
HOMA2-β 844 126.95±45.20
HOMA2-IR 844 1.09±0.58
Data are expressed as arithmetic mean±standard deviation or percentages. BMI: body mass index; HOMA-β:
homeostasis model assessment-β-cell function; HOMA-IR: homeostasis model assessment-insulin resistance.
https://doi.org/10.1371/journal.pone.0230032.t001
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The genotypes of all SNPs were determined by SNPscanTM technology (Genesky Biotech-
nologies Inc., Shanghai, China), which was based upon double ligation and multiplex fluores-
cence polymerase chain reactions. For quality control purpose, we randomly selected 5.5% of
the samples and performed genotyping twice independently, which yielded >99% concor-
dance rates. In 99.9% or more of the samples, each polymorphism was successfully genotyped
(S1 Table). All 35 SNPs genotyped were in Hardy-Weinberg equilibrium (HWE) with P>0.05.
Statistical analysis
HWE was tested for each polymorphism separately using a χ2 test. The strength of pairwise LD
between the 35 variants was measured as r2 using the online platforms SHEsis (http://analysis.
bio-x.cn/myAnalysis.php) and SNPStats (http://bioinfo.iconcologia.net/snpstats/start.htm).
Pairwise variants exhibit low LD (r2<0.50), moderate high LD (0.80>r2>0.50), high LD
(r2>0.80) and perfect LD (r2 = 1). If r2 between two variants is <0.80, they were thought to be
independent.
The impact of the 35 SNPs on glycemic traits including 24-28-week FPG, plasma glucose 1
hour after a 50-gram glucose challenge test, fasting insulin, HOMA1-β, HOMA1-IR, HOMA2-
β and HOMA2-IR, were assessed using analysis of variance (ANOVA). Analysis of covariance
(ANCOVA) was carried out for adjustment of age at childbirth, neonatal sex, prepregnancy gra-
vidity and prepregnancy parity. Fasting insulin levels, HOMA1-β, HOMA1-IR, HOMA2-β and
HOMA2-IR were natural log transformed to approximate normality before ANOVA and
ANCOVA. In each analysis, cases with missing data were simply dropped and then the remain-
ing data were analyzed. Statistical analyses were done using Statistical Package for Social Science
(SPSS) version 15.0 (Chicago, IL, USA). In the initial analyses, P<0.05 were considered statisti-
cally significant. To account for multiple testing, Bonferroni correction was applied.
Results
The r2 values of 9 SNP pairs (i.e. SNP 1 and 3, SNP 2 and 4, SNP 5 and 6, SNP 11 and 13, SNP
15 and 16, SNP 17 and 19, SNP 24 and 28, SNP 26 and 27, as well as SNP 33 and 34) were all
above 0.80, which showed high LD between them (Fig 1). The effective number of independent
variants was considered for Bonferroni correction. Accordingly, the corrected significant P
value was arbitrarily set to 0.002 (i.e. 0.05/26) for ADCY5 for it corresponds to an adjusted P
value of 0.05 divided by the number of independent SNPs (26) in the 35 SNPs. We next ana-
lyzed the associations between the 35 SNPs and gestational glycemic traits. For brevity, only
the results of statistical tests as P<0.05 are indicated in Table 2. As shown, five statistically sig-
nificant associations were found.
Significant differences were observed in 24-28-week plasma glucose 1 hour after a 50-gram
glucose challenge test among the genotype groups of three SNPs (rs6797915, rs9856662 and
rs9875803). Plasma glucose 1 hour after a 50-gram glucose challenge test was significantly
higher in homozygous carriers of the minor allele C of SNP rs6797915 compared with carriers
of the major allele G (P = 0.042). It was also significantly increased in homozygous carriers of
the major allele of SNP rs9856662 or rs9875803 as compared to carriers of the corresponding
minor allele (P = 0.018).
One SNP (rs6777397) was related to HOMA1-β (P = 0.014): women carrying heterozygous
genotype GA of SNP rs6777397 had significantly higher HOMA1-β as compared to those car-
rying homozygous genotype GG or AA.
One SNP (rs6762009) was correlated with HOMA1-IR (P = 0.033): HOMA1-IR in women
homozygous for the minor allele C was significantly lower than that in those with the major
allele G.
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When adjusted for age at childbirth, neonatal sex, prepregnancy gravidity and prepreg-
nancy parity, the effect of rs6797915 was no longer significant whereas those of rs9856662,
rs9875803, rs6777397 and rs6762009 remained significant. There were no significant differ-
ences between the 35 SNPs and 24-28-week FPG, fasting insulin, HOMA2-β as well as
HOMA2-IR. No significant associations were detected at the 0.002 level. In other words, none
of these associations passed Bonferroni correction.
Discussion
In the present study, we examined whether 35 ADCY5 common variants were related to glyce-
mic traits during pregnancy, including FPG, plasma glucose 1 hour after a 50-gram glucose
challenge test, fasting plasma insulin, HOMA1-β, HOMA2-β, HOMA1-IR, and HOMA2-IR in
Chinese Han women. Five associations were observed at P<0.05 but none of them would
withstand Bonferroni correction for multiple comparisons with a P value threshold of 0.002
for statistical significance.
In 2010, two parallel meta-analysis of GWASs in nongravid individuals of European
descent identified variants at ADCY5 (SNP rs11708067 and rs2877716) associated with fasting
and 2-hour glucose as well as T2DM [12, 13]. SNP rs11708067 and rs2877716 are in high LD
(r2 = 0.82). These results suggest that ADCY5 may be involved in glucose metabolism.
Fig 1. Pairwise linkage disequilibrium between SNPs, as measured by r2, in the ADCY5 gene. Numbers within diamonds indicate the r2 value between the
two SNPs defined by the upper left and the upper right sides of the diamond. For example, r2 between rs6801826 (SNP 1) and rs6777397 (SNP 2) is 0.03. The
plot was generated by the SHEsis Online Version. Key: r2 = 0 is given in white, and 0< r2� 1 is given in shades of red (redder color represents higher r2).
https://doi.org/10.1371/journal.pone.0230032.g001
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Since then, a number of studies have attempted to replicate the associations of ADCY5 vari-
ants with glycemic traits and/or T2DM. However, most of these studies were conducted in
populations of European descent and reported positive results [20–24]. A study, which was
performed in a population consisting of 56.4% of European descent and 43.6% of non-Euro-
pean descent, also got positive results [25]. Three studies were conducted in Asians, two in
Chinese Han [26, 27] and one in South Asians of Punjabi ancestry [28]. Of note, most studies
investigated only one or two ADCY5 variants (i.e. SNP rs11708067 and/or rs2877716) [20–26,
28]. The effects of other ADCY5 variants on glycemic traits, especially in populations of non-
European ancestry, remained largely unknown. Our study analyzed 35 ADCY5 SNPs in a Chi-
nese Han population.
Hu et al. (2010) [26] investigated only two ADCY5 variants (SNP rs11708067 and
rs2877716) and Sun et al. (2015) [27] investigated SNP rs11708067 and rs9883204. SNP
rs9883204 is in perfect LD with rs2877716 in many populations such as CHB, Utah residents
of northern and western European ancestry from the CEPH collection (CEU) (r2 = 1) (data
derived from the 1000 Genomes Project, based on GRCh38). These two studies were both con-
ducted in Chinese Han and failed to replicate the associations with the risk of T2DM or
impaired glucose metabolism and glycemic traits. SNP rs11708067, rs2877716 and rs9883204
are much rarer in Chinese Han (MAF 0.002–0.005) than they are in the European ancestry
populations (MAF 0.130–0.250). There might be insufficient statistical power to replicate the
effects of the three variants because of their rarity. It is unclear whether there are other ADCY5
variants with effects on glucose metabolism in Chinese Han. Therefore, the present study
included another 35 SNPs other than the three variants.
In addition to SNP rs11708067 and rs9883204, Sun et al. (2015) [27] also investigated SNP
rs6777397 (SNP 2), rs9881942, rs4678017 and rs7641344 (SNP 27). In CHB and CHS
Table 2. Association between ADCY5 common variants and gestational glycemic traits.
Genotype N Mean(95% confidence interval) P Pa
24-28-week 1-hour plasma glucose after a 50-gram glucose challenge test, mmol/l
SNP 21 rs6797915 GG 355 7.10(6.96–7.24) 0.042 0.067
GC 407 7.07(6.93–7.21)
CC 118 7.44(7.13–7.76)
SNP 24 rs9856662 CC 681 7.20(7.09–7.32) 0.018 0.019
CA 186 6.88(6.68–7.08)
AA 14 6.78(6.09–7.47)
SNP 28 rs9875803 TT 675 7.21(7.10–7.32) 0.018 0.019
TC 191 6.88(6.69–7.08)
CC 15 6.84(6.20–7.48)
HOMA1-β
SNP 2 rs6777397 GG 574 165.17(156.05–174.82) 0.014 0.022
GA 249 189.04(173.11–206.44)
AA 35 145.21(117.71–179.14)
HOMA1-IR
SNP 30 rs6762009 GG 270 1.53(1.42–1.64) 0.033 0.044
GC 418 1.57(1.48–1.66)
CC 169 1.36(1.23–1.50)
Values are reported as unadjusted arithmetic mean (95% confidence interval) for plasma glucose and geometric mean (95% confidence interval) for other variables as
well as only for variants meeting significance criteria (P<0.05) in analysis of variance.
a Adjusted with analysis of covariance for age at childbirth, neonatal sex, prepregnancy gravidity and prepregnancy parity.
https://doi.org/10.1371/journal.pone.0230032.t002
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populations, SNP rs9881942 and rs4678017 were in high LD with rs2332510 (SNP 19) and
rs11923120 (SNP 20), respectively (both r2>0.976) (data derived from the 1000 Genomes Proj-
ect, based on GRCh38). They only observed that SNP 27 was associated with HOMA1-β
(P = 0.02) and fasting insulin levels (P = 0.05). Note that they did not apply multiple testing
corrections. In the present study, SNP 27 was not related to any gestational glycemic traits
investigated even before multiple testing corrections. Among SNP 2, 19, 20 and 27, the present
study only showed SNP 2 was associated with HOMA1-β but the association did not pass Bon-
ferroni correction. Discrepancies between the studies may be due to the facts that (1) the
indexes of glucose metabolism in the study of Sun et al. were measured during non-pregnancy
while the indexes in the present study were measured during pregnancy, and (2) only 52% of
the participants in the study of Sun et al. were female while the participants in the present
study were all female.
To our knowledge, until now, there have been only two studies on the relationship between
ADCY5 genetic variants and glucose metabolism in pregnant women [14, 15]. Huopio et al.
(2013) [14] observed that SNP rs11708067 was associated with GDM and OGTT 2-hour glu-
cose level in Finnish pregnant women. Arora et al. (2018) [15] also found that SNP rs11708067
was associated with GDM in South Asian pregnant women of Punjabi ancestry. Both studies
focused on only one genetic variant of the ADCY5 gene (i.e., SNP rs11708067) which is rare in
Chinese Han.
Most studies in non-pregnant European populations have consistently shown that ADCY5
genetic variants were related to glycemic traits and/or T2DM, and two studies have reported
that SNP rs11708067, a genetic variant of ADCY5, was associated with GDM. Functional stud-
ies also showed that ADCY5 is involved in glucose metabolism. To date, genetic studies of
ADCY5 were mainly conducted in non-pregnant European populations, but less in non-Euro-
pean populations and pregnant populations. Genetic variants of ADCY5 have large allele fre-
quency difference among different races. Therefore, it is necessary to confirm the relationship
between genetic variants of ADCY5 and glucose metabolism particularly in non-European
populations and pregnant populations.
Due to both differential LD structure between populations and differences in SNP coverage,
the present study assessed the relationship between 35 ADCY5 SNPs and glycemic traits in a
Chinese Han pregnant population and identified five statistical significant associations. How-
ever, the five associations were weak, i.e., with P values ranging from 0.042 to 0.014, and none
of them could withstand Bonferroni correction for multiple comparisons. This is a limitation
of the study. Another limitation is the lack of functional evidence. The five statistical signifi-
cant SNPs have not yet been identified as true causal variants. Therefore, the current findings
should be considered preliminary and need to be validated by further investigations using
large replication samples.
Conclusions
In summary, the present study comprehensively evaluated the genetic associations of common
variants in ADCY5 with gestational glycemic traits in a Chinese Han population and identified
five variants associated with gestational glycemic traits before Bonferroni correction. Follow-
ing Bonferroni correction, these associations became insignificant. Therefore, these nominally
significant associations still need to be verified in other populations. Our findings expanded
the body of knowledge about the effects of ADCY5 on glycemic traits, especially in non-Euro-
pean descent populations and during pregnancy, although the effects need to be addressed in
future studies.
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